Plasmodium vivax can cause severe malaria associated with substantial morbidity and mortality, show two studies published in PLoS Medicine. These findings challenge the current dogma that P.

Researchers from the Institut de Parasitologie et de Pathologie Tropicale at the University of Strasbourg and the Laboratoire de Parasitologie et de Mycologie Médicale at the Strasbourg University ...

Brazilian researchers have developed a synthetic compound that has the potential to treat malaria and block its transmission.

The horizontal transfer of DNA between different organisms is a major force shaping the genomes of prokaryotes, but is considered to have a minor role in eukaryotes, with only a handful of known ...

A novel study indicates promising avenues in an innovative approach for developing a vaccine against Plasmodium vivax, the most prevalent human malaria parasite outside sub-Saharan Africa. The study ...

Experts want closer attention to plasmodium vivax parasite in the fight against malaria. The complete sequence of the vivax genome has now been reported. Experts want closer attention to plasmodium ...

Plasmodium vivax is a major cause of malaria morbidity worldwide yet has remained genetically intractable. To stably modify this organism, we used zinc-finger nucleases (ZFNs), which take advantage of ...

Background. Evidence of the presence of Plasmodium vivax in the placenta is scarce and inconclusive. This information is relevant to understanding whether P. vivax affects placental function and how ...

A study indicates the possibility of using tiny vesicles derived from human immature red blood cell as a vaccine platform. A novel study indicates promising avenues in an innovative approach for ...